Cerebrospinal fluid levels of soluble CD14 in inflammatory and non-inflammatory diseases of the CNS: upregulation during bacterial infections and viral meningitis
Wa. Nockher et al., Cerebrospinal fluid levels of soluble CD14 in inflammatory and non-inflammatory diseases of the CNS: upregulation during bacterial infections and viral meningitis, J NEUROIMM, 101(2), 1999, pp. 161-169
The CD14 antigen, an important cell surface molecule of monocytic cells, is
involved in cellular activation: it binds lipopolysaccharide and other cel
lular lipid structures. Brain macrophages play a pivotal role during inflam
matory reactions of the CNS parenchyma, ventricles and meninges. A soluble
form of CD14 (sCD14) was measured in paired cerebrospinal fluid (CSF) and s
erum samples from 91 patients with different neurological diseases. Mean le
vels of circulating sCD14 in CSF in a control group of 22 patients with neu
rologic complaints but no neurological deficit on clinical examination were
0.19 +/- 0.06 (mean +/- SD) mg/l. The CSF/blood ratios of sCD14 was 49 +/-
16 X 10(-3), while those of albumin were 4.4 +/- 1.4 X 10(-3). These extre
mely high CSF/blood ratios of the sCD14 molecule compared to albumin indica
te a local cerebral production. No significant changes in CSF sCD14 levels
were found in patients with non-inflammatory neurological diseases (NID). I
n contrast, CSF sCD14 levels were markedly elevated during acute meningitis
, but there was no direct correlation between sCD14 and monocyte count in t
he CSF. Thus, sCD14 could not originate in the CSF compartment from monocyt
es alone. The highest values for sCD14 were found in CSF during infections
with various pathogens such as Staphylococcus aureus or Listeria monocytoge
nes. While sCD14 serum levels dramatically increased during acute bacterial
meningitis, sCD14 ratios did not correlate with albumin ratios during the
course of disease. Therefore, increased CSF sCD14 may originate from cerebr
al production by activated or infiltrated macrophages rather than passive d
iffusion from the blood, while elevated sCD14 serum levels resulted from en
hanced local production. Increased CSF and serum sCD14 values were also obs
erved in meningitis caused by viral infection. As in bacterial meningitis,
sCD14 in CSF specimens did not correlate with the function of the blood/CSF
barrier. Repeated lumbar punctures revealed a normalization of CSF sCD14 l
evels during clinical recovery. These results provide the first evidence fo
r local production of sCD14 within the CNS. Our findings further indicate t
hat sCD14 in CSF is a reliable marker for activation of macrophages within
the CNS during inflammatory processes. (C) 1999 Elsevier Science B.V. All r
ights reserved.